Cargando…
Advancement of NF-κB Signaling Pathway: A Novel Target in Pancreatic Cancer
Pancreatic ductal adenocarcinoma (PDAC) is one of the deadliest cancers and is the third highest among cancer related deaths. Despite modest success with therapy such as gemcitabine, pancreatic cancer incidence remains virtually unchanged in the past 25 years. Among the several driver mutations for...
Autores principales: | Pramanik, Kartick C., Makena, Monish Ram, Bhowmick, Kuntal, Pandey, Manoj K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6320793/ https://www.ncbi.nlm.nih.gov/pubmed/30563089 http://dx.doi.org/10.3390/ijms19123890 |
Ejemplares similares
-
Wnt/β-Catenin Signaling: The Culprit in Pancreatic Carcinogenesis and Therapeutic Resistance
por: Ram Makena, Monish, et al.
Publicado: (2019) -
Targeting the complement system in pancreatic cancer drug resistance: a novel therapeutic approach
por: Hussain, Naushair, et al.
Publicado: (2022) -
The NF-κB Signaling Pathway, the Microbiota, and Gastrointestinal Tumorigenesis: Recent Advances
por: Peng, Chao, et al.
Publicado: (2020) -
NF-κB Dependent Chemokine Signaling in Pancreatic Cancer
por: Geismann, Claudia, et al.
Publicado: (2019) -
Large Population Analysis of Secondary Cancers in Pediatric Leukemia Survivors
por: Yavvari, Siddhartha, et al.
Publicado: (2019)